PMC:7172841 / 1468-1625 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":4,"end":7},"obj":"Body_part"},{"id":"T16","span":{"begin":19,"end":28},"obj":"Body_part"},{"id":"T17","span":{"begin":36,"end":40},"obj":"Body_part"},{"id":"T18","span":{"begin":45,"end":52},"obj":"Body_part"},{"id":"T19","span":{"begin":48,"end":52},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":94,"end":102},"obj":"Disease"},{"id":"T22","span":{"begin":149,"end":157},"obj":"Disease"},{"id":"T23","span":{"begin":149,"end":153},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":19,"end":28},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T15","span":{"begin":32,"end":35},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T16","span":{"begin":36,"end":40},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T17","span":{"begin":45,"end":52},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":8,"end":10},"obj":"Chemical"},{"id":"T13","span":{"begin":106,"end":108},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":29,"end":102},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T50","span":{"begin":4,"end":7},"obj":"PR:000029150"},{"id":"T51","span":{"begin":14,"end":18},"obj":"PR:000001889"},{"id":"T52","span":{"begin":19,"end":28},"obj":"CL:0000576"},{"id":"T53","span":{"begin":94,"end":102},"obj":"SP_7"},{"id":"T54","span":{"begin":106,"end":110},"obj":"PR:000001393"},{"id":"T55","span":{"begin":119,"end":130},"obj":"DG_35"},{"id":"T52417","span":{"begin":4,"end":7},"obj":"PR:000029150"},{"id":"T73916","span":{"begin":14,"end":18},"obj":"PR:000001889"},{"id":"T86003","span":{"begin":19,"end":28},"obj":"CL:0000576"},{"id":"T91561","span":{"begin":94,"end":102},"obj":"SP_7"},{"id":"T288","span":{"begin":106,"end":110},"obj":"PR:000001393"},{"id":"T45776","span":{"begin":119,"end":130},"obj":"DG_35"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}

{"project":"LitCovid-PubTator","denotations":[{"id":"74","span":{"begin":14,"end":18},"obj":"Gene"},{"id":"79","span":{"begin":32,"end":35},"obj":"Gene"},{"id":"80","span":{"begin":45,"end":63},"obj":"Disease"},{"id":"81","span":{"begin":94,"end":102},"obj":"Disease"},{"id":"85","span":{"begin":106,"end":110},"obj":"Gene"},{"id":"87","span":{"begin":119,"end":130},"obj":"Chemical"}],"attributes":[{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"Gene:929"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Gene:920"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:D054066"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:C000657245"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:3569"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV"}